Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|June 10, 2008
Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant womenMatthieu Roustit, Malik Jlaiel, Pascale Leclercq, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 14, 2021
COVID-19 lockdowns and incidence of psychoactive substance exposure according to age and sexAurélien Spinelli, Theo Willeman, Matthieu Roustit, et al.
Pharmacology & Therapeutics|July 14, 2020
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatmentFrançoise Stanke-Labesque, Elodie Gautier-Veyret, Stephanie Chhun, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 12, 2026
Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?Capucine Arrivé, Marie Hotot, Jean-François Jourdil, et al.
Journal of Clinical Medicine|October 14, 2022
Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug MonitoringLéa Bolcato, Anne Thiebaut-Bertrand, Françoise Stanke-Labesque, et al.
Therapie|November 1, 2020
[Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic]Anaëlle Chavant, Elodie Gautier-Veyret, Stéphanie Chhun, et al.
British Journal of Pharmacology|September 12, 2003
Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated ratsFrançoise Stanke-Labesque, Gaëlle Hardy, Françoise Caron, et al.
Inflammatory Bowel Diseases|February 21, 2008
Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activityFrançoise Stanke-Labesque, Joanna Pofelski, Alexandre Moreau-Gaudry, et al.
Pageof 10